|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $732 and $643, respectively | ||||||||||||||||||||
| Deferred costs, short term | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net of accumulated depreciation of $269 and $227, respectively | ||||||||||||||||||||
| Right of use assets | ||||||||||||||||||||
| Deferred costs, long term | ||||||||||||||||||||
| Intangible assets, net of accumulated amortization of $15,384 and $13,251, respectively | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Term loan, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long term liabilities: | ||||||||||||||||||||
| Term loan, net | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Contingent consideration, long term | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Common stock, $0.00001 par value, 50,000 shares authorized, 12,676 and 12,383 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
